GLPGX Trademark

Trademark Overview

On Thursday, April 9, 2026, a trademark application was filed for GLPGX with the United States Patent and Trademark Office. The USPTO has given the GLPGX trademark a serial number of 99754630. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, April 9, 2026. This trademark is owned by Aranscia LLC. The GLPGX trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Diagnostic tests and clinical services used to assist in the guidance and assessment of an individual’s potential response to specific medications, peptides, and/or other therapies
glpgx

General Information

Serial Number99754630
Word MarkGLPGX
Filing DateThursday, April 9, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateThursday, April 9, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDiagnostic tests and clinical services used to assist in the guidance and assessment of an individual’s potential response to specific medications, peptides, and/or other therapies

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, April 9, 2026
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAranscia LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressHouston, TX 77025-5730
US

Trademark Events

Event DateEvent Description
Thursday, April 9, 2026NEW APPLICATION ENTERED
Thursday, April 9, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 9, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

glpgx specific response potential medications peptides therapies other individual assessment clinical